“…These findings suggest that it is possible to deduce qualitative rules for predicting the activity of EA analogues, taking into account their chemical differences from the parental compound [67]. Conversely, two other semisynthetic derivatives, such as 3,3 ′ -di-beta-Dglucopyranosylellagic acid decaacetate and 3,3 ′ -di-n-octyl-4,4 ′ -dihexanoylellagic acid, were less effective than EA in inhibiting lung tumour formation after exposure of A/J mice to benzo[a]pyrene [68]. Interestingly, the peracetate derivative (3,4,3,4-tetra-O-acetylellagic acid) was more efficient than EA in protecting bone marrow and lungs from genotoxicity induced by aflatoxin B 1 [69].…”